Immunitas Therapeutics, Inc. — Form D

Immunitas Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-24. The offering totals $57.7M, of which $29.1M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-08-24
• Form: D
• Accession: 0001879910-21-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $57.7M
• Amount sold: $29.1M
• Remaining: $28.6M
• Investors: 21
• Date of first sale: 2021-08-10
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-411076

Issuer

• Name: Immunitas Therapeutics, Inc.
• CIK: 0001879910
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 830 WINTER STREET, 2ND FLOOR, WALTHAM, MA, 02451
• Phone: 781-810-9292

Officers, directors & promoters (10)

More

• CIK 1879910 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search